Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells

European Journal of Cancer

Volumn 45, Issue 3, 2009, Pages 454-460

  Naldini, Antonella ^a   Filippi, Irene ^a   Ardinghi, Camilla ^a   Silini, Antonietta ^b   Giavazzi, Raffaella ^b   Carraro, Fabio ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Breast cancer; Cell survival; Hypoxia; Protease activated receptor 1; Tumour microenvironment

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEINASE ACTIVATED RECEPTOR 1; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL DEATH; CELL MIGRATION; CELL PROTECTION; CELL SURVIVAL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIC CELL; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL SURVIVAL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM PROTEINS; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION; THROMBIN;

EID: 59149088848     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.10.012     Document Type: Article

References (33)

1. Chinni C., de Niese M.R., Tew D.J., Jenkins A.L., Bottomley S.P., and Mackie E.J. Thrombin, a survival factor for cultured myoblasts. J Biol Chem 274 (1999) 9169-9174
2. Goldsack N.R., Chambers R.C., Dabbagh K., and Laurent G.J. Thrombin. Int J Biochem Cell Biol 30 (1998) 641-646
3. Bar-Shavit R., Kahn A., Fenton J.W.I., and Wilner G.D. Chemotactic response of monocytes to thrombin. J Cell Biol 96 (1983) 282-285
4. Sambrano G.R., and Coughlin S.R. The carboxyl tail of protease-activated receptor-1 is required for chemotaxis. Correlation of signal termination and directional migration. J Biol Chem 274 (1999) 20178-20184
5. Coughlin S.R. Thrombin signalling and protease-activated receptors. Nature 407 (2000) 258-264
6. Ossovskaya V.S., and Bunnett N.W. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84 (2004) 579-621
7. Massi D., Naldini A., Ardinghi C., et al. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma. Hum Pathol 36 (2005) 676-685
8. Tellez C., and Bar-Eli M. Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene 22 (2003) 3130-3137
9. Yin Y.J., Salah Z., Maoz M., et al. Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation. FASEB J 17 (2003) 163-174
10. Kallinowski F., Schlenger K.H., Runkel S., et al. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res 49 (1989) 3759-3764
11. Graeber T.G., Osmanian C., Jacks T., et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379 (1996) 88-91
12. Yu J.L., Coomber B.L., and Kerbel R.S. A paradigm for therapy-induced microenvironmental changes in solid tumors leading to drug resistance. Differentiation 70 (2002) 599-609
13. Naldini A., Carney D.H., Pucci A., and Carraro F. Human alpha-thrombin stimulates proliferation of interferon-gamma differentiated, growth-arrested U937 cells, overcoming differentiation-related changes in expression of p21CIP1/WAF1 and cyclin D1. J Cell Physiol 191 (2002) 290-297
14. Salah Z., Maoz M., Pokroy E., Lotem M., Bar-Shavit R., and Uziely B. Protease-activated receptor-1 (hPar1), a survival factor eliciting tumor progression. Mol Cancer Res 5 (2007) 229-240
15. Nguyen Q.D., De W.O., Bruyneel E., et al. Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho-Rho kinase axis and tumor microenvironment. Oncogene 24 (2005) 8240-8251
16. Minafra S., Morello V., Glorioso F., et al. A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast. Br J Cancer 60 (1989) 185-192
17. Naldini A., and Carraro F. Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation. J Cell Physiol 181 (1999) 448-454
18. 2 tension measurements. Cancer Res 51 (1991) 3316-3322
19. Jacobson M.D., Burne J.F., and Raff M.C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13 (1994) 1899-1910
20. Naldini A., Bernini C., Pucci A., and Carraro F. Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytes. J Leukoc Biol 78 (2005) 736-744
21. Schioppa T., Uranchimeg B., Saccani A., et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198 (2003) 1391-1402
22. Buccione R., Baldassarre M., Trapani V., et al. Glycerophosphoinositols inhibit the ability of tumour cells to invade the extracellular matrix. Eur J Cancer 41 (2005) 470-476
23. Naldini A., Leali D., Pucci A., et al. Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes. J Immunol 177 (2006) 4267-4270
24. Vandesompele J., De P.K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 (2002) 1-12
25. Carraro F., Pucci A., Pellegrini M., Pelicci P.G., Baldari C.T., and Naldini A. P66Shc is involved in promoting HIF-1alpha accumulation and cell death in hypoxic T cells. J Cell Physiol 211 (2007) 439-447
26. Boire A., Covic L., Agarwal A., Jacques S., Sherifi S., and Kuliopulos A. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120 (2005) 303-313
27. Kataoka H., Hamilton J.R., McKemy D.D., et al. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 102 (2003) 3224-3231
28. i and p38 MAPK activation in Jurkat T cells: implication of the tyrosine kinase p56Lck. Blood 91 (1998) 4232-4241
29. Huang C., Jacobson K., and Schaller M.D. MAP kinases and cell migration. J Cell Sci 117 (2004) 4619-4628
30. Page E.L., Robitaille G.A., Pouyssegur J., and Richard D.E. Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem 277 (2002) 48403-48409
31. Chalmers C.J., Balmanno K., Hadfield K., Ley R., and Cook S.J. Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1. Biochem J 375 (2003) 99-109
32. Yin Y.J., Katz V., Salah Z., et al. Mammary Gland Tissue Targeted Overexpression of Human Protease-Activated Receptor 1 Reveals a Novel Link to {beta}-Catenin Stabilization. Cancer Res 66 (2006) 5224-5233
33. Shin I., Kim S., Song H., Kim H.R., and Moon A. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Chem 280 (2005) 14675-14683